Eli Lilly and Co

Johnson & Johnson

Merck & Co Inc

Roche Holding AG

AstraZeneca PLC

Novartis AG

Pfizer Inc

Sanofi SA

Bristol-Myers Squibb Co

Zoetis Inc

GSK plc

Merck KGaA

Novo Nordisk A/S

Jiangsu Hengrui Pharmaceuticals Co Ltd

Ucb SA

Bayer AG

Sun Pharmaceutical Industries Ltd

Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Hansoh Pharmaceutical Group Company Ltd

Viatris Inc

Fredun Pharmaceuticals Ltd. engages in the manufacture and sale of pharmaceuticals, neutraceuticals, herbal and dietary supplements. The company is headquartered in Mumbai, Maharashtra and currently employs 260 full-time employees. The company went IPO on 2016-03-17. The firm is primarily engaged in the business of pharmaceuticals and healthcare. The firm operates through four segments: Generics (Exports & Fredun Gx), Pet Healthcare (Freossi), Nutraceuticals (Fredun Nutrition) and Cosmeceuticals (Bird and Beauty or BnB). The company offers a range of products, including antihypertensive, antidiabetic, antiretroviral drugs (ARVs) and narcotics. The company is also engaged in the manufacturing of dietary /herbal supplements, nutraceuticals, and other healthcare products along with animal healthcare products. The firm primarily exports its products to Africa, Southeast Asia, Commonwealth of Independent States (CIS) countries and Latin America.

Fredun Pharmaceuticals Ltd

Fredun Темп роста прибыли

Что такое Темп роста прибыли ?

Какой показатель «Темп роста прибыли» у Fredun ?